Merck agreed to buy Cidara Therapeutics, the maker of an experimental flu therapy, in a $9.2 billion deal, as the ...

Jenna Norton, a vocal critic of Trump administration actions at the NIH, was abruptly placed on administrative leave this ...

Weight loss drugs have skyrocketed in prevalence in recent years, according to a new KFF poll on GLP-1 drugs and drug prices.

Merck is buying Cidara Therapeutics for $9.2B, picking up an experimental flu therapy as it looks to broaden its pipeline.

A strategic and financial recalibration on psychiatric drug development brings profound implications for investors, insurers, ...

There are a few unusual things about the infant botulism outbreak that prompted formula maker ByHeart to recall all of its ...

There are many reasons why a 79-year-old man might need to get an MRI scan of his brain, some benign, some more concerning.

A closely watched next-generation blood thinner being developed by Bristol Myers Squibb and Johnson & Johnson failed in one of three late-stage trials.

What does Rick Pazdur's new role mean for the FDA? And how much credit can the president take for lowering GLP-1 drug prices?

The FDA approved a drug made by Kura Oncology to treat patients with a certain type of genetically altered leukemia.

Marty Makary and Vinay Prasad offered a roadmap for expanding access to custom gene-editing treatments like the one used to ...

Republicans want to replace enhanced ACA tax credits with direct payments to individuals. Their think tank allies aren’t so ...